Shares of Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $127.57.
Several research analysts have recently weighed in on the company. Macquarie assumed coverage on Addus HomeCare in a research report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Oppenheimer lifted their price objective on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd.
Check Out Our Latest Stock Analysis on Addus HomeCare
Insider Buying and Selling at Addus HomeCare
Hedge Funds Weigh In On Addus HomeCare
Hedge funds and other institutional investors have recently modified their holdings of the business. Principal Securities Inc. purchased a new position in Addus HomeCare in the fourth quarter valued at approximately $26,000. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Quest Partners LLC purchased a new position in Addus HomeCare in the second quarter valued at approximately $31,000. EntryPoint Capital LLC purchased a new position in Addus HomeCare in the first quarter valued at approximately $44,000. Finally, Innealta Capital LLC purchased a new position in Addus HomeCare in the second quarter valued at approximately $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Addus HomeCare Trading Down 2.0 %
Shares of ADUS opened at $130.44 on Monday. The company has a market capitalization of $2.36 billion, a PE ratio of 32.37, a PEG ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $136.12. The stock’s 50-day moving average price is $127.07 and its two-hundred day moving average price is $114.28.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.94 EPS. Equities research analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Breakout Stocks: What They Are and How to Identify Them
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.